Healthcare provider profile · identity verified

Robin Ray Shook, ANP-BC

Nurse Practitioner · CADILLAC, MI · NPI 1699857748

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	312	52
Lisinopril	Lisinopril	292	71
Atorvastatin Calcium	Atorvastatin Calcium	263	64
Albuterol Sulfate Hfa	Albuterol Sulfate	238	71
Omeprazole	Omeprazole	218	59
Metformin Hcl	Metformin Hcl	211	55
Levothyroxine Sodium	Levothyroxine Sodium	173	42
Metoprolol Tartrate	Metoprolol Tartrate	171	38
Rosuvastatin Calcium	Rosuvastatin Calcium	147	39
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	108	42
Furosemide	Furosemide	107	29
Amlodipine Besylate	Amlodipine Besylate	104	29
Gabapentin	Gabapentin	102	24
Simvastatin	Simvastatin	101	23
Famotidine	Famotidine	100	29
Pregabalin	Pregabalin	99	18
Hydrochlorothiazide	Hydrochlorothiazide	98	21
Losartan Potassium	Losartan Potassium	96	28
Tramadol Hcl	Tramadol Hcl	95	29
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	93	21
Celecoxib	Celecoxib	91	22
Metoprolol Succinate	Metoprolol Succinate	88	26
Eliquis	Apixaban	80	18
Alprazolam	Alprazolam	77	17
Jardiance	Empagliflozin	68	14
Sertraline Hcl	Sertraline Hcl	66	19
Montelukast Sodium	Montelukast Sodium	63	17
Pravastatin Sodium	Pravastatin Sodium	63	16
Atrovent Hfa	Ipratropium Bromide	62	17
Tamsulosin Hcl	Tamsulosin Hcl	57	16
Januvia	Sitagliptin Phosphate	55	11
Pantoprazole Sodium	Pantoprazole Sodium	54	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	54	13
Trazodone Hcl	Trazodone Hcl	53	17
Aripiprazole	Aripiprazole	50	12
Duloxetine Hcl	Duloxetine Hcl	50	12
Alendronate Sodium	Alendronate Sodium	46	suppressed
Meloxicam	Meloxicam	45	14
Quetiapine Fumarate	Quetiapine Fumarate	45	suppressed
Atenolol	Atenolol	43	13
Ezetimibe	Ezetimibe	39	suppressed
Potassium Chloride	Potassium Chloride	39	14
Carvedilol	Carvedilol	38	suppressed
Citalopram Hbr	Citalopram Hydrobromide	38	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Fluticasone Propionate	Fluticasone Propionate	37	12
Azithromycin	Azithromycin	36	30
Ibuprofen	Ibuprofen	35	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	suppressed
Allopurinol	Allopurinol	33	suppressed
Methylprednisolone	Methylprednisolone	33	32
Fenofibrate	Fenofibrate Nanocrystallized	32	suppressed
Ventolin Hfa	Albuterol Sulfate	32	17
Naproxen	Naproxen	31	18
Xarelto	Rivaroxaban	29	suppressed
Clopidogrel	Clopidogrel Bisulfate	28	12
Testosterone Cypionate	Testosterone Cypionate	28	suppressed
Mounjaro	Tirzepatide	27	suppressed
Glipizide	Glipizide	25	suppressed
Spironolactone	Spironolactone	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Sucralfate	Sucralfate	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Ketoconazole	Ketoconazole	22	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Ozempic	Semaglutide	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	21
Lovastatin	Lovastatin	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Cephalexin	Cephalexin	19	15
Clonazepam	Clonazepam	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	16
Farxiga	Dapagliflozin Propanediol	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	17	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	13
Metformin Hcl Er	Metformin Hcl	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Bumetanide	Bumetanide	16	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Calcitriol	Calcitriol	16	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Methotrexate	Methotrexate Sodium	16	suppressed
Nystatin	Nystatin	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	13
Glipizide Er	Glipizide	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Bupropion Hcl	Bupropion Hcl	14	suppressed
Hydrocortisone	Hydrocortisone	14	12
Invokana	Canagliflozin	14	suppressed
Prednisone	Prednisone	14	11
Sulfasalazine Dr	Sulfasalazine	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Bydureon Bcise	Exenatide Microspheres	13	suppressed
Clindamycin Hcl	Clindamycin Hcl	13	13
Fenofibrate	Fenofibrate	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Lorazepam	Lorazepam	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Finasteride	Finasteride	12	suppressed
Glyburide	Glyburide	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Ingrezza	Valbenazine Tosylate	12	suppressed
Jantoven	Warfarin Sodium	12	suppressed
Lamotrigine Er	Lamotrigine	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Nadolol	Nadolol	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Digoxin	Digoxin	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error